Massachusetts General Hospital, Dana Farber Cancer Center — Boston, Massachusetts

Massachusetts General Hospital, Dana Farber Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital, Dana Farber Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Vanderbilt-Ingram Cancer Center.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital, Dana Farber Cancer Center?

Massachusetts General Hospital, Dana Farber Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital, Dana Farber Cancer Center conducted?

Massachusetts General Hospital, Dana Farber Cancer Center has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is Massachusetts General Hospital, Dana Farber Cancer Center accredited by Crixeo Health?

Massachusetts General Hospital, Dana Farber Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital, Dana Farber Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.